Evidence map›Paper›PMID 41067712›Full record

ReviewJournal of neonatal-perinatal medicine2026

Does the duration of empiric antibiotic treatment influence NEC incidence and severity relative to placental pathology?

Parvesh Mohan Garg, Liza Konnikova, Suhas G Kallapur, Jeffrey S Shenberger

Abstract readReview
In one paragraph

Review in Journal of neonatal-perinatal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Parvesh Mohan GargDepartment of Pediatrics/Neonatology, Atrium Health Wake Forest Baptist, Wake Forest School of Medicine, Winston Salem, NC, USA.ORCID 0000-0001-5949-7304
Liza KonnikovaDivision of Neonatology, Department of Pediatrics, Yale School of Medicine, New Haven, CT, USA.
Suhas G KallapurDepartment of Pediatrics/Neonatology, UCLA Mattel Children's Hospital, Los Angeles, CA, USA.
Jeffrey S ShenbergerDepartment of Pediatrics/Neonatology, Connecticut Children's, Hartford, CT, USA.

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI HALL, JOHN E · 2016 to 2025
$38.2M
NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

Necrotizing enterocolitis (NEC) remains a leading cause of mortality in preterm infants. Studies show that exposure to chorioamnionitis is associated with increased rate of NEC. The influence of the early antibiotic exposure provides contrasting findings, with a few studies demonstrating an increased risk of NEC with prenatal and postnatal antibiotic treatment, and others showing a decreased NEC risk. Far fewer reports delineate the impact of the duration of early antibiotics or the potential confounding of antibiotics by placental pathology on incidence of NEC. The provision of antibiotics following birth is associated with increased risk of NEC secondary to changes in the gut microbiome, intestinal epithelium maturation, and the intestinal barrier function. This report presents current evidence about the clinical impact of intrauterine environment and postnatal antibiotic exposure on the intestinal injury in preterm infants. We present information from our own research in conjunction with information collected from an extensive search in the databases PubMed, EMBASE, and Scopus. Both translational and prospective clinical studies are needed to fully understand the combined impact of placental pathology and postnatal antibiotic exposure on the neonatal morbidities and mortality.

Indexed as

Anti-Bacterial AgentsChorioamnionitisEnterocolitis, NecrotizingInfant, Premature, DiseasesPlacentaFemaleGastrointestinal MicrobiomeHumansIncidenceInfant, NewbornInfant, PrematurePregnancyAnti-Bacterial AgentsantibioticschorioamnionitisNECoutcomesplacentapreterm infant

Identifiers

PMID41067712
PMCPMC12670245

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.